Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics Inc | RCV000712646 | SCV000843164 | pathogenic | not provided | 2018-08-03 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000712646 | SCV000927973 | pathogenic | not provided | 2018-10-04 | criteria provided, single submitter | clinical testing | |
Molecular Biology Laboratory, |
RCV001281267 | SCV001425192 | pathogenic | Polycystic kidney disease, adult type | 2020-02-01 | criteria provided, single submitter | research | |
Gene |
RCV000712646 | SCV001872626 | pathogenic | not provided | 2022-06-21 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33532864, Izzi2020[abstract], 29529603, 11012875, 29633482, 22508176, 25333066, 25525159) |
Fulgent Genetics, |
RCV001281267 | SCV002790539 | pathogenic | Polycystic kidney disease, adult type | 2022-03-17 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001292115 | SCV001480947 | pathogenic | Polycystic kidney disease | no assertion criteria provided | clinical testing | The PKD1 p.Arg2402* variant was identified in 7 of 3596 proband chromosomes (frequency: 0.002) from individuals or families with autosomal dominant polycystic kidney disease and was not identified in 110 control chromosomes from healthy individuals (Xu 2018, Neumann 2013, Trujillano 2014, Phakdeekitcharoen 2000, Audrézet 2012, Hwang 2016). It was also identified in ClinVar (1x as Pathogenic by one submitter) and in the ADPKD Mutation Database (classified as Definitely Pathogenic). The variant was not identified in dbSNP, LOVD 3.0 or in the PKD1-LOVD databases. It was not identified in the following control databases: the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The p.Arg2402* variant leads to a premature stop codon at position 2402, which is predicted to lead to a truncated or absent protein and loss of function. Loss of function variants of the PKD1 gene are an established mechanism of disease in autosomal dominant polycystic kidney disease and is the type of variant expected to cause the disorder. In summary, based on the above information this variant meets our laboratory’s criteria to be classified as pathogenic. |